Description of Research Expertise:
Dr. Doubeni's research is on colorectal cancer focusing on racial and socioeconomic disparities in mortality and on the effectiveness of screening. He currently leads National Institute of Health-funded multisite studies of the comparative effectiveness colorectal cancer screening and is a co-principal investigator of one of three colorectal cancer research centers of the PROSPR (Population-Based Research Optimizing Screening through Personalized Regimens) network. The PROSPR center, based in Kaiser Permanente in Northern and Southern California, is examining critical questions about factors that limit the optimal performance or effectiveness of colorectal cancer screening (with colonoscopy or fecal immunochemical test) in order to remediate avoidable failures in the process of screening. Dr. Doubeni received a 2010 Presidential Early Career Award for Scientists and Engineers (PECASE) for his work on cancer screening comparative effectiveness research, mentoring and community service.
US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld S, Mangione CM, Silverstein M, Simon MA, Tseng CW: Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement
JAMA 319 (11): 1134-1142,2018.
Harris RA, Haberer JE, Musinguzi N, Chang KM, Schechter CB, Doubeni CA, Gross R.: Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model PLoS One 13 (3): e0194713,2018.
Doubeni CA, Miller E, Alston R: Live Broadcast Panel: WURD Radio sponsored "Healthy Aging Event" WURD Radio : 2018.
Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Stephen Sy, Alagoz O, Stout NK, Lansdorp-Vogelaar I, Corley DA, Tosteson A: Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study
Cancer Epidemiol Biomarkers Prev 27 (2): 158-164,2018.
US Preventive Services Task Force., Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW: Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement JAMA
319 (6): 588-594,2018.
Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose P, Quinn V, Jensen C, Chubak J, Tiro J, Doubeni CA, Ghai N, Sugg Skinner C, Wernli K, Halm EA: Patterns and predictors of repeat fecal occult blood test screening in four large health systems in the United States Am J Gastroenterol : 2018.
Doubeni CA, Corley DA, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson JR, Mehta SJ, Becerra TA, Zhao WK, Schottinger J, Doria-Rose VP, Levin TR, Weiss NS, Fletcher RH: Effectiveness of Screening Colonoscopy in Reducing the Risk of Death from Right and Left Colon Cancer: A Large Community-based Study Gut 67 (2): 291-298,2018.
Emmons K, Doubeni CA, Fernandez ME, Miglioretti DL, Samet JM: National Institutes of Health Pathways to Prevention Workshop: Methods for Evaluating Natural Experiments in Obesity
National Institutes of Health: Office of Disease Prevention : 2018.
Kurth AE, Krist AH, Borsky AE, Baumann LC, Curry SJ, Davidson KW, Doubeni CA, Epling Jr. JW, Fan T, Garcia FAR, Herzstein J, Phillips WR, Pignone MP, Tseng CW, Weinstein R: U.S. Preventive Services Task Force Methods to Communicate and Disseminate Clinical Preventive Services Recommendations
Am J Prev Med 54 (1): S81–S87,2018.
Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K: Timely Follow-Up of Positive Cancer Screening Results: A Systematic Review and Recommendation From the PROSPR Consortium CA Cancer J Clin : 2018.
View all publications